Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01673425 · ClinicalTrials.gov registry record · NA
Evaluating Immune Response to Seasonal FluMist in Healthy Adults
A NA study, sponsored by National Center for Occupational Health and Infection Control.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01673425 is a NA study that was terminated before completion, run by National Center for Occupational Health and Infection Control. The registered enrollment target is 5 participants.
The verdict
NCT01673425, a NA study, was terminated before completion, sponsored by National Center for Occupational Health and Infection Control.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The Live-Attenuated Influenza Vaccine (LAIV), also known as FluMist, has been shown to be effective in children but less effective in adults. Our hypothesis is that this relative failure is due to adults having enough anti-flu IgA antibody in nasal secretions to neutralize the weakened vaccine virus.
Interventions
- DRUG Live Attenuated Influenza Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-09 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01673425
The ClinicalTrials.gov registry entry for NCT01673425 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Occupational Health and Infection Control, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Live Attenuated Influenza Vaccine is the first listed.
NCT01673425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01673425 about?
NCT01673425 is a clinical study titled "Evaluating Immune Response to Seasonal FluMist in Healthy Adults". The Live-Attenuated Influenza Vaccine (LAIV), also known as FluMist, has been shown to be effective in children but less effective in adults. Our hypothesis is that this relative failure is due to adults having enough anti-flu IgA antibody in nasal secretions to neutralize the weakened vaccine virus...
What is the current status of trial NCT01673425?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2012-09. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01673425?
The interventions under investigation include: Live Attenuated Influenza Vaccine (DRUG).
Who is sponsoring clinical trial NCT01673425?
This trial is sponsored by National Center for Occupational Health and Infection Control, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.